February 16, 2026
Seprod Limited (SEP)
Unaudited financials for the twelve months ended December 31, 2025:
Seprod Limited (SEP) for the twelve months ended December 31, 2025, reported a 15% increase in revenue, totalling $153.63 billion compared to $133.61 billion in the corresponding period last year. Revenue for the fourth quarter increased by 1% to close at $40.58 billion compared to $40.18 billion for the comparable quarter of 2024.
Cost of sales amounted to $112.61 billion (2024: $94.54 billion), representing a 19% increase year over year. Consequently, gross profit increased by 5% to $41.02 billion compared to $39.07 billion for the twelve months ended December 31, 2024. The company booked gross profit of $10.90 billion for the fourth quarter versus $11.94 billion reported for the similar quarter of 2024.
Finance and other operating income increased by 101% to close at $4.14 billion (2024: $2.06 billion), while other operating expenses totalled $33.08 billion (2024: $32.14 billion). As a result, operating profit for the twelve months ended December 31, 2025, amounted to $12.07 billion, a 34% increase relative to $8.99 billion reported in 2024.
Finance costs for the twelve months ended December 31, 2025, increased by 19% to $4.86 billion (2024: $4.09 billion).
Share of results of associate and joint venture for the twelve months ended December 31, 2025, amounted to $339.11 million, a 51% decrease relative to $688.90 million reported in 2024. Share of results of associate and joint venture for the fourth quarter amounted to $84.59 million (2024: $396.38 million). Profit before taxation for the twelve months totalled $7.56 billion, a 35% increase from the corresponding period last year (2024: $5.59 billion). For the fourth quarter, profit before taxation amounted to $3.34 billion compared to $1.15 billion in the corresponding quarter of 2024, representing a 191% increase.
Taxation charge for the twelve months ended December 31, 2025, amounted to $1.76 billion, a 21% decrease relative to $2.22 billion reported in 2024. Taxation charge for the fourth quarter amounted to $656.69 million (2024: $815.31 million).
Net profit from continuing operations for the twelve months ended December 31, 2025, increased by 72% to reach $5.80 billion (2024: $3.37 billion). For the fourth quarter, net profit from continuing operations amounted to $2.69 billion compared to $334.88 million in the corresponding quarter of 2024, representing a 703% increase.
Net loss for the period from discontinued operations for the twelve months amounted to $75.09 million (2024: loss of $42.89 million). For the fourth quarter, net loss from discontinued operations was $22.39 million (2024: gain of $16.94 million).
Net profit for the twelve months ended December 31, 2025, increased by 72% to reach $5.72 billion (2024: $3.33 billion). For the fourth quarter, net profit amounted to $2.67 billion compared to $351.82 million in the corresponding quarter of 2024, representing a 658% increase.
Net profit attributable to shareholders for the twelve months ended December 31, 2025, amounted to $4.99 billion, compared to $2.61 billion reported in 2024. For the fourth quarter, net profit attributable to shareholders was $2.44 billion (2024: $198.00 million).
Consequently, earnings per share for the twelve months amounted to $5.48 (2024: EPS: $3.56), while earnings per share for the quarter totalled $2.68 (2024: EPS: $0.22). The twelve-month trailing EPS was 5.48, and the number of shares used in these calculations was 910,945,538.
Notably, SEP’s stock price closed the trading period on February 13, 2026, at $79.15, with a corresponding P/E ratio of 14.44x.
Balance Sheet Highlights
The company’s assets totalled $142.70 billion (2024: $135.57 billion). This increase was attributable to trade and other receivables which amounted to $37.93 billion (2024: $32.58 billion).
Shareholders’ equity was $39.42 billion (2024: $29.58 billion), representing a book value per share of $43.27 (2024: $32.48).
Disclaimer:
Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
